Clinical Trial Update: Effect of Meibomian Gland Probing on Ocular Surface in Ocular Rosacea [NA]

View source ↗

Summary

The clinical trial evaluating meibomian gland probing for ocular surface disease in ocular rosacea has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meibomian Gland Dysfunction
• Ocular Rosacea

Snippet

Sponsor: University of Arkansas | Conditions: Meibomian Gland Dysfunction | NA | Status: WITHDRAWN